Brevan Howard Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Sell
91,800
-174,372
-66% -$909K ﹤0.01% 1400
2025
Q4
$1.33M Sell
266,172
-118,765
-31% -$618K 0.01% 646
2025
Q3
$1.95M Sell
384,937
-506,777
-57% -$2.23M 0.01% 574
2025
Q2
$3.84M Buy
891,714
+832,408
+1,404% +$4.11M 0.02% 468
2025
Q1
$358K Sell
59,306
-10,616
-15% -$53.7K ﹤0.01% 812
2024
Q4
$276K Sell
69,922
-134,578
-66% -$603K ﹤0.01% 802
2024
Q3
$1.2M Buy
204,500
+101,295
+98% +$499K 0.01% 398
2024
Q2
$445K Buy
103,205
+82,169
+391% +$394K ﹤0.01% 652
2024
Q1
$98.9K Sell
21,036
-33,538
-61% -$128K ﹤0.01% 895
2023
Q4
$268K Buy
54,574
+34,829
+176% +$171K ﹤0.01% 769
2023
Q3
$108K Buy
+19,745
New +$158K ﹤0.01% 347

Other funds holding MPT

Brevan Howard Capital Management's MPT Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Medical Properties Trust (MPT) stake by 66% in Q1 2026, selling an estimated $909K and leaving 91,800 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Brevan Howard Capital Management first reported a position in MPT in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.84M in Q2 2025. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Brevan Howard Capital Management held 91,800 shares of Medical Properties Trust worth $425K as of Q1 2026.
  • Brevan Howard Capital Management sold 174,372 Medical Properties Trust shares in Q1 2026, an estimated $909K.
  • Medical Properties Trust made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1400 holding.
  • Brevan Howard Capital Management first reported a position in Medical Properties Trust in Q3 2023 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Medical Properties Trust position peaked at $3.84M in Q2 2025.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.